Research Report on Chinese Carbapenem antimicrobial drugs Market (2008 Edition)
(we keep updating the report with new information)

    Price: US$1,900
    Contact: Mr. Bian chenghua Ms. Wu huifang
    Tel.: 86-10-68012929-2116/2101 Fax: 86-10-68052505
    E-mail: bianch@healthoo.com wuhf@healthoo.com
    http://www.healthoo.com

The production and export size of Chinese Carbapenems drugs increased with a rapid speed in the past few years. In the terms of bulk Carbapenems, the output of bulk Meropenem had increased to 7 ton in 2007 from 3 ton in 2006. Four main manufacturers produce bulk Meropenem. The output of bulk mipenem was about 1 ton, but the import of bulk mipenem from South Korea increased obviously in past 2 years.

Now thera are 5 Carbapenems in Chinese market. The sales size of finished drugs of Carbapenems in 2007 increased by 46% compared to last year. The market size was 1.3 billion Yuan, 10 million vials.

    In order to reflect the practical sales size, we combine the practical import amount of certain brands and the sales data from 250 sample hospital to estimate out the market size of Chinese carbapenems markt. The report also presents the competitive status, the development trend of carbapenems, the production and export status of bulk carbapenems, the need amount for bulk carbapenems. This report can provide valuable information and comments for the enterprises which want to know Chinese carbapenems markt or the export of bulk carbapenems.

    Table of Contents Abstract
    Overview of products
    1 General situation of international market of carbapenem Antibiotics
    2 Carbapenem drugs market in China
    2.1 National market scale and growth trend from 2003 to 2007
    2.2 Shares and variation trend of national carbapenem drugs from 2003 to 2007
    2.3 Sale volume and growth trend of Imipenem/Cilastatin from 2003 to 2007
    2.4 Sale volume and growth trend of Meropenem from 2003 to 2007
    2.5 Sale volume and growth trend of Panipenem/Betamipron from 2003 to 2007
    2.6 Sales Status of Import and Domestic Carbapenem Drugs
    2.7 Evaluation on demand volume of carbapenem Bulk Drugs
    3. Shares of brands
    3.1 Market share variation and advantage appraisal of the 12 brands 
    3.1.1 Market share variation of the 6 brands
    3.1.2 Shares of brands in 2007
    3.1.3 Sales Analysis on Different Brand Names of Meropenem from 2003 to 2007
    3.1.4 Sales Analysis on Different Brand Names of Imipenem from 2003 to 2007
    3.2 Market Shares of Different Brand Names in Sample Cities in 2006
    “Tienam”(Imipenem/Cilastatin)
    “BeiNeng”(Meropenem)
    “Mepem” (Meropenem)
    “Invanztm” (Ertapenem)
    “Carbenin”(Panipenem/Betamipron)
    “Haizheng MeiTe” (Meropenem)
    “BACQURE” (Imipenem/Cilastatin)
     “SuNeng” (Imipenem/Cilastatin)
    “Prepenem” (Imipenem/Cilastatin)
    “Jianing” (Imipenem/Cilastatin)
    “Zhongnuo Shunuoke” (Imipenem/Cilastatin)
    “Imipenem (Haizheng)” (Imipenem/Cilastatin)
    3.3 Market Shares of Different Brand Names in Major Cities in 2007
    Beijing
    Shanghai
    Guangzhou
    Hangzhou
    Chengdu
    Nanjing
    4. Research and Development of new products
    4.1 Domestic and imported products on Chinese market
    4.2 Imitation and Application Status of Carbapenem Antimicrobial Drugs in China
    4.2.1 Types of products
    4.2.2 Application Enterprises
    4.3 Background of other carbapenem drugs about to enter into Chinese market
    Biapenem
    Doripenem
    4.4 Penems products: comparison of Faropenem to carbapenems
    4.5 Clinical evaluation of anti-severe infection drugs
    4.5.1 Main characters of carbapenem antibiotics
    4.5.2 Clinical evaluation of carbapenems
    4.6 Products in process of development in the world currently
    Appendix 1 List of Enterprises Submited Applications for Carbapenems to SFDA
    Appendix 2 Retail Prices of Different Carbapenems with Different Strengths